DiscoveryDecember10th,2020By DDN StaffPlasma protein partnershipUK Biobank announces that 10 biopharmaceutical companies will take part in a consortium to measure circulating plasma proteins
Clinical ResearchDecember2nd,2020By Mel J. YeatesOnto the Fast Track for MarzAACatalyst Biosciences gains FDA Fast Track designation for subcutaneous MarzAA for the treatment of Hemophilia
September8th,2020By DDN StaffGC Pharma partners with Atomwise for hemophiliaGC Pharma taps Atomwise to expand its hemophilia franchise
September2nd,2020By Mel J. YeatesPolygenic scores can predict predisposition to blood diseasesStudies identify bulk of genetic variations that influence blood cell traits
June4th,2020By Mel J. YeatesA device for detecting blood clotsBiomedical engineering researchers design a medical device that mimics blood vessels
June2nd,2020By DDN StaffTargeted drugs and immunotherapies may lower risk of hematologic cancersTrend of reduced therapy-related hematologic cancers among patients with three cancer types likely driven by immune modulation, Roswell Park team proposes
June2nd,2020By DDN StaffAiming to better tackle relapsePurdue startup gets $2 million SBIR grant to fast-track cancer drug platform technology
June2nd,2020By Mel J. YeatesA potential COVID-19 treatment gears up for trialsRevive Therapeutics files a Pre-CTA meeting request with Health Canada for Bucillamine in the treatment of COVID-19
June1st,2020By DDN StaffNegative Data Prize is a positive?Global Preclinical Data Forum says sharing negative science results is key to neuroscience progress
May31st,2020By Ilene SchneiderWell-tolerated tumor drugAntibody therapeutic from Compugen demonstrates no dose-limiting toxicities